Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03657108 · ClinicalTrials.gov registry record · NA
CivaSheet With Radical Prostatectomy & Adjuvant External Beam Radiation
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03657108 is a NA study that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 6 participants.
The verdict
NCT03657108, a NA study, was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
A phase I single-arm open label dose escalation study to evaluate the maximum tolerated dose (MTD) and safety of Civasheet® with radical prostatectomy (RP) and adjuvant external beam radiation therapy (EBRT) in a 3+3 dose escalation design among participants with high risk prostate cancer (PCa).
Interventions
- RADIATION Civasheet 60 Gy
- RADIATION Civasheet 75 Gy
- RADIATION Adjuvant external beam radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-03-27 |
| Est. Completion | 2023-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03657108
The ClinicalTrials.gov registry entry for NCT03657108 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Civasheet 60 Gy is the first listed.
NCT03657108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03657108 about?
NCT03657108 is a clinical study titled "CivaSheet With Radical Prostatectomy & Adjuvant External Beam Radiation". A phase I single-arm open label dose escalation study to evaluate the maximum tolerated dose (MTD) and safety of Civasheet® with radical prostatectomy (RP) and adjuvant external beam radiation therapy (EBRT) in a 3+3 dose escalation design among participants with high risk prostate cancer (PCa).
What is the current status of trial NCT03657108?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2018-03-27. Estimated completion is 2023-02-01.
What interventions are being tested in trial NCT03657108?
The interventions under investigation include: Civasheet 60 Gy (RADIATION), Civasheet 75 Gy (RADIATION), Adjuvant external beam radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT03657108?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.